AFFECTIS Trademark

Trademark Overview

On Wednesday, March 30, 2005, a trademark application was filed for AFFECTIS with the United States Patent and Trademark Office. The USPTO has given the AFFECTIS trademark a serial number of 78598051. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 19, 2014. This trademark is owned by Affectis Pharmaceuticals AG. The AFFECTIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, psychotropic preparations, and preparations for treating diseases and disorders of the central nervous system and of the neural pathways in general
affectis

General Information

Serial Number78598051
Word MarkAFFECTIS
Filing DateWednesday, March 30, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 19, 2014
Registration Number3381742
Registration DateTuesday, February 12, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, psychotropic preparations, and preparations for treating diseases and disorders of the central nervous system and of the neural pathways in general

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 19, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAffectis Pharmaceuticals AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMunich 80804
DE
Party NameAffectis Pharmaceuticals AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMunich 80804
DE
Party NameAffectis Pharmaceuticals AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMunich 80804
DE

Trademark Events

Event DateEvent Description
Friday, September 19, 2014CANCELLED SEC. 8 (6-YR)
Tuesday, February 12, 2008REGISTERED-PRINCIPAL REGISTER
Wednesday, January 9, 20081(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, January 9, 2008NOTICE OF ALLOWANCE CANCELLED
Monday, January 7, 2008TEAS DELETE 1(B) BASIS RECEIVED
Thursday, January 3, 2008EXTENSION 1 GRANTED
Monday, July 9, 2007EXTENSION 1 FILED
Wednesday, December 26, 2007EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, December 26, 2007PETITION TO REVIVE-GRANTED
Wednesday, December 26, 2007TEAS PETITION TO REVIVE RECEIVED
Monday, December 24, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Thursday, December 6, 2007ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 9, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2006PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2006NOTICE OF PUBLICATION
Wednesday, August 30, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 25, 2006ASSIGNED TO LIE
Monday, August 21, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 19, 2006AMENDMENT FROM APPLICANT ENTERED
Tuesday, August 1, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 1, 2006PAPER RECEIVED
Thursday, May 11, 2006LETTER OF SUSPENSION MAILED
Wednesday, May 10, 2006SUSPENSION LETTER WRITTEN
Wednesday, May 10, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 3, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 3, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 27, 2005NON-FINAL ACTION MAILED
Wednesday, October 26, 2005NON-FINAL ACTION WRITTEN
Wednesday, October 26, 2005ASSIGNED TO EXAMINER
Tuesday, April 5, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

affectis preparations system nervous neural pathways general central disorders namely psychotropic